6505-01-219-3900 ( NDC00015-0549-41 , NDC00015-0549-41 , CYTOXAN )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-219-3900 6505 012193900 CYCLOPHOSPHAMIDE FOR INJECTION,U 3083
NSN Features
MRC Parameter Characteristics
CRLK PRIMARY CONTAINER CONTENT QUANTITY 2.000 GRAMS OF ACTIVE INGREDIENT
CBBL FEATURES PROVIDED STERILE
AJCN PROTECTIVE STORAGE FEATURE ANTINEOPLASTIC DRUG
CQCT PRIMARY CONTAINER TYPE VIAL
AGXW PHYSICAL FORM FREEZE-DRIED POWDER
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY CYCLOPHOSPHAMIDE FOR INJECTION USP 2GM VIAL FREEZE DRIED POWDER 6S
CQPQ WARNING AND CAUTION STATEMENTS CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
CSCW TOTAL PRIMARY CONTAINER QUANTITY 6
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 2.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
NDC00015-0549-41 0NUD3 A 2 5 4 ZZ
NDC00015-0549-41 29398 A 2 3 4 KX
CYTOXAN 29398 A 1 5 4 KX
Manufacturers
Part SKU Cage Manufacturer Type Status
NDC00015-0549-41 0NUD3 BRISTOL-MYERS SQUIBB COMPANY F A
NDC00015-0549-41 29398 MEAD JOHNSON & COMPANY, LLC A A
CYTOXAN 29398 MEAD JOHNSON & COMPANY, LLC A A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 10/26/1 P 3004909140 3083
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DA C2201X- A V DISCONTINUED W/O REPLACEMENT
DS I V DISCONTINUED W/O REPLACEMENT
DS I K U/I CONTAINS 6 EA
DN 9L----- N K U/I CONTAINS 6 EA
VA V K U/I CONTAINS 6 EA
DN 9L----- N V DISCONTINUED W/O REPLACEMENT
DA C2201X- A K U/I CONTAINS 6 EA
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DN SMS Y 1 PG K U 9L----- N
DS SMS Y 1 PG K U D
VA I 1 PG M U V
DA SMS Y 1 PG K U C2201X- A
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC
058770 Z 33400 W 532 Z 9 A M Z DRUGS/MEDICINES/VITAMINS NOI